Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

For the final time in it’s illustrious history, The Big House crowned it’s final small school state champions. Holden Krusemark spent the day at Jim Norick Arena as six gold basketballs were ...

LEWISBURG — The PIAA Class 2A girls diving championships took place at Bucknell’s Kinney Natatorium on Wednesday, and Hampton’s Gab Elk was crowned state champion behind a 433-point outing.

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

In fewer than seven days, the green flag will wave at the Australian Grand Prix, kicking off the 75th season of Formula 1 racing. The 2025 season might seem like a forgone conclusion after Max ...

Forsythe was stellar throughout Dale's state title run. He averaged 23.6 points and recorded 10 points, 10 rebounds and five assists in the title game to help lead Dale to its fourth straight ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...